ATHA icon

Athira Pharma
ATHA

Overview Fund Activity

98 hedge funds and large institutions have $71.9M invested in Athira Pharma in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 20 closing their positions.

Holders
98
Holders Change
–
Holders Change %
0%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
34
Reduced
17
Closed
20
Calls
$2.5M
Puts
$254K
Net Calls
+$2.25M
Net Calls Change
-$5.8M

Top Buyers

1
PFO
1
Pathstone Family Office
New Jersey
$10.8M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$748K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$1.03M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$698K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.44M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$474K
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.31M
3
LGM
3
Logos Global Management
California
$0
4
JG
4
Jefferies Group
New York
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$187K
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
126
Simplex Trading
Illinois
– – – –
HGERS
127
Householder Group Estate & Retirement Specialist
Arizona
$0 150 +150 New
2 3 4 5
6